vimarsana.com
  1. Home
  2. Live Updates
  3. Updated Prescription Drug User Fee Act - Breaking News

Latest Breaking News On - Updated prescription drug user fee act - Page 1 : vimarsana.com

Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U S Food and Drug Administration for Subcutaneous Nivolumab Co-Formulated with ENHANZE®

/PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Bristol Myers Squibb was reassigned a Prescription Drug User Fee.

San diegoUnited statesEli lillyBristol myers squibbSamantha gasparIdorsia pharmaceuticalsHalozyme therapeutics incExchange commissionCorporate communicationsPrnewswire halozyme therapeutics incDrug administrationAcumen pharmaceuticalsTeva pharmaceuticalsUpdated prescription drug user fee actPrescription drug user fee actBiologics license application

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.